1362 related articles for article (PubMed ID: 35876829)
1. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2020 May; 5(5):CD005259. PubMed ID: 32374919
[TBL] [Abstract][Full Text] [Related]
4. Treatment of distal deep vein thrombosis.
Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic anticoagulants for non-hospitalised people with COVID-19.
Santos BC; Flumignan RL; Civile VT; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD015102. PubMed ID: 37591523
[TBL] [Abstract][Full Text] [Related]
6. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of deep vein thrombosis.
Wang X; Ma Y; Hui X; Li M; Li J; Tian J; Wang Q; Yan P; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010956. PubMed ID: 37058421
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological interventions for preventing venous thromboembolism in people undergoing bariatric surgery.
Amaral FC; Baptista-Silva JC; Nakano LC; Flumignan RL
Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013683. PubMed ID: 36413425
[TBL] [Abstract][Full Text] [Related]
8. Oral direct thrombin inhibitors or oral factor Xa inhibitors versus conventional anticoagulants for the treatment of pulmonary embolism.
Li M; Li J; Wang X; Hui X; Wang Q; Xie S; Yan P; Tian J; Li J; Xie P; Yang K; Yao L
Cochrane Database Syst Rev; 2023 Apr; 4(4):CD010957. PubMed ID: 37057837
[TBL] [Abstract][Full Text] [Related]
9. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Broderick C; Yeoh SE; Stansby G
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD010837. PubMed ID: 34597414
[TBL] [Abstract][Full Text] [Related]
10. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism.
Kakkos S; Kirkilesis G; Caprini JA; Geroulakos G; Nicolaides A; Stansby G; Reddy DJ
Cochrane Database Syst Rev; 2022 Jan; 1(1):CD005258. PubMed ID: 35089599
[TBL] [Abstract][Full Text] [Related]
11. Effect of testing for cancer on cancer- or venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Broderick C; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD010837. PubMed ID: 30407621
[TBL] [Abstract][Full Text] [Related]
12. Thrombolytic strategies versus standard anticoagulation for acute deep vein thrombosis of the lower limb.
Broderick C; Watson L; Armon MP
Cochrane Database Syst Rev; 2021 Jan; 1(1):CD002783. PubMed ID: 33464575
[TBL] [Abstract][Full Text] [Related]
13. Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy.
Perrotta C; Chahla J; Badariotti G; Ramos J
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD005259. PubMed ID: 35993965
[TBL] [Abstract][Full Text] [Related]
14. Pentasaccharides for the treatment of deep vein thrombosis.
Brandao GM; Junqueira DR; Rollo HA; Sobreira ML
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011782. PubMed ID: 29199766
[TBL] [Abstract][Full Text] [Related]
15. Vena caval filters for the prevention of pulmonary embolism.
Young T; Sriram KB
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD006212. PubMed ID: 33027844
[TBL] [Abstract][Full Text] [Related]
16. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
Robertson L; Yeoh SE; Stansby G; Agarwal R
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
[TBL] [Abstract][Full Text] [Related]
17. Pentasaccharides for the prevention of venous thromboembolism.
Dong K; Song Y; Li X; Ding J; Gao Z; Lu D; Zhu Y
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005134. PubMed ID: 27797404
[TBL] [Abstract][Full Text] [Related]
18. Primary prophylaxis for venous thromboembolism in people undergoing major amputation of the lower extremity.
Herlihy DR; Thomas M; Tran QH; Puttaswamy V
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD010525. PubMed ID: 32692430
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Civile VT; Tinôco JDS; Pascoal PI; Areias LL; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2022 Mar; 3(3):CD013739. PubMed ID: 35244208
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome.
Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
